高压氧联合化疗对卵巢上皮性癌疗效研究

目的 探讨高压氧联合PC方案化疗对卵巢上皮性癌初治患者的疗效.方法 将58例卵巢上皮性癌术后患者采用随机数字表法分为研究组(30例)和对照组(28例),对照组给予环磷酰胺1000 mg/m2+顺铂75 mg/m2,21 d为1个疗程,至少6个疗程.研究组在高压氧2个标准大气压下暴露60 min,出舱25～30 min给予对照组方法化疗.比较两组的近期疗效和3年存活率、无进展生存时间以及不良反应等.结果 研究组近期总有效率、未控率、复发率、复发时间、3年存活率分别为83.3%(25/30)、6.7%(2/30)、33.3%(10/30)、(21.0±0.8)个月、43.3%(13/30),明显优于对照组的67.9%(19/28)、17.9%(5/28)、46.4%(13/28)、(18.0±0.6)个月、17.9%(5/28)(P＜0.05).研究组无进展生存时间和总生存时间明显长于对照组(P＜0.05),且不良反应发生率明显低于对照组(P＜0.05).结论 卵巢上皮性癌的辅助化疗中,高压氧联合PC方案疗效优于单纯PC方案,且高压氧能明显减少PC方案不良反应.

Study of therapeutic efficacy of hyperbaric oxygen combined with chemotherapy on epithelial ovarian cancer

Objective To discuss the therapentic efficacy of hyperbaric oxygen combined with PC program in newly diagnosed epithelial ovarian cancer patients. Methods Fifty-eight patients with epithelial ovarian cancer were divided into two groups by random digits table: HBO group(30 cases) and PC group(28cases). HBO group were exposed to hyperbaric oxygen of 2 standard atmospheric pressure 60 min, then given chemotherapy 25-30 min after extravehicular: cyclophosphamide 1000 mg/m2 + cisplatin 75 mg/m2.PC group with the same regimen without hyperbaric oxygen therapy were analyzed. The two groups were compared in the efficacy and 3-year survival rate, progression-free survival and adverse reactions. Results The total effective rate, not controlled rate, recurrence rate,recurrence time, 3-year survival rate in HBO group 83.3%(25/30),6.7%(2/30),33.3%(10/30), (21.0 ± 0.8) months,43.3%(13/30)] were better than those in PC group 67.9% (19/28), 17.9% (5/28), 46.4% (13/28), (18.0 ± 0.6) months, 17.9% (5/28)] (P ＜0.05), progression-free survival and overall survival time in HBO group were longer than those in PC group (P ＜0.05) and adverse reactions rate in HBO group was lower than that in PC group (P ＜0.05).Conclusions The hyperbaric oxygen combined with PC programs are better than PC programs in advanced epithelial ovarian cancer chemotherapy response rate, progression-free survival time and 3-year survival rates in ovarian cancer adjuvant chemotherapy. HBO can significantly reduce the PC's hematological toxicity and toxicity of the digestive system.